EPIRUS BIOPHARMACEUTICALS IN's ticker is EPRSQ and the CUSIP is 29428P107. A total of 45 filers reported holding EPIRUS BIOPHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 1,847,500 | $5,709,000 | 0.37% |
| Cormorant Asset Management, LP | 896,600 | $2,770,000 | 0.33% |
| Broadfin Capital, LLC | 1,375,000 | $4,249,000 | 0.26% |
| SOUTHPORT MANAGEMENT, L.L.C. | 25,000 | $77,000 | 0.14% |
| TPG Group Holdings (SBS) Advisors, Inc. | 2,223,922 | $6,872,000 | 0.05% |
| BAILARD, INC. | 35,000 | $108,000 | 0.05% |
| HIGHLAND CAPITAL MANAGEMENT LP | 438,276 | $1,355,000 | 0.04% |
| Spark Investment Management LLC | 93,900 | $290,000 | 0.04% |
| Abingworth LLP | 7,896 | $24,000 | 0.01% |
| SIMPLEX TRADING, LLC | 43,008 | $132,000 | 0.01% |